Array CGH designed to detect the loss and gain of genome and chromosome regions responsible for up to 124 genetic syndromes associated with intellectual disability and congenital disorders. Specifically aimed at prenatal diagnosis, its powerful design reduces diagnostic complexity and improves the resolution of conventional karyotyping by up to 50 times in the critical regions of the syndromes being tested.
NIMGenetics offers QF-PCR (Quantitative Fluorescence Polymerase Chain Reaction) as a complementary test to KaryoNIM® Prenatal, to rule out the presence of complete triploidy.
When is it recommended?*
At least in the following situations:
(*): AEDP recommendations for the use of microarrays (Suela J et al. Med Clin (Barc). 2017; 148(7):328.e1–328.e8)
Turnaround time: 3 -5 working days from receipt of the sample.
Please remember to attach the Application Form and Informed Consent Form to the sample, which you will find on the right.
NIMGenetics offers specialists QF-PCR (Quantitative Fluorescence Polymerase Chain Reaction) technology to test prenatal samples.
When is it indicated in prenatal samples?